Urethral Stricture Treatment Market Current Trends And Lucrative Opportunities In Technology – 2027
Published by Coherent Market Insights
Posted on September 27, 2021
4 min readLast updated: February 2, 2026

Published by Coherent Market Insights
Posted on September 27, 2021
4 min readLast updated: February 2, 2026

The Urethral Stricture Treatment market is set to grow with increasing prevalence and technological advancements, driven by prostate cancer cases.
Urethral Stricture Treatment Market report includes historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in the related industry. Urethral Stricture Treatment Market offers complete, proficient report delivering market research data that is relevant for new market entrants or set up players. Key strategies of the companies operating in the market and their impact analysis have been included in the report.
Request for Sample Copy of Report at – https://www.coherentmarketinsights.com/insight/request-sample/2381
Urethral strictures can be caused by diagnostic or therapeutic urological procedures. As a result of the increasing geriatric population, these demand for these procedures is also increasing. Therefore, prevalence of urethral strictures is expected to become more common over the forecast period. Urethral stricture is more prevalent in men than in females. According to data published by the National Centers for Biotechnology & Information (NCBI) in January 2016, the prevalence of urethral stricture is around 200 per 100,000 in males below 65 years in the U.S.
The global urethral stricture treatment market is estimated to be valued at US$ 1,326.0 million in 2019, and is expected to exhibit a CAGR of 6.0% during the forecast period (2019–2027).
Increasing incidence of prostate cancer, injuries, and medical conditions requiring urethral stents, dilators, and catheters is expected to drive growth of the market over the forecast period
According to data published by the National Centers for Biotechnology & Information (NCBI), urethral stricture is a common disease with prevalence of over 400 per 100,000 males across the globe in 2016. According to Cancer Research UK, prostate cancer is the most common cancer with around 47,200 new cases registered in 2015 among males in the U.K. Moreover, the incidence of prostate cancer is projected to increase by 12% between 2014 and 2035, to 233 cases per 100,000 males by 2035 in the U.K., as per Cancer Research UK. Therefore, the rising incidences of urethral stricture is expected to drive growth of the market.
In addition to increasing incidence of urethral stricture, the high success rate of the procedure is also expected to facilitate growth of the urethroplasty segment during the forecast period. For instance, according to the British Association of Urological Surgeons (BAUS) Limited, urethroplasty is the most preferred procedure for treatment of urethral strictures and has a success rate of over 85.0% compared to other procedures
Major Key Players are: Paragonix Technologies, Inc., Organ Transport Systems, Pulse Heart Transportation System, and others. Key players in the market are focused on launching new heart transport systems in order to enhance their market share. For instance, in December 2018, Paragonix Technologies received approval from the U.S. Food and Drug Administration (FDA) for its Paragonix Sherp, a cardiac transport system.
Intent of the Urethral Stricture Treatment Market Research Study:
Purchase this Premium Report (Flat USD 2000 OFF) – https://www.coherentmarketinsights.com/promo/buynow/2381
Reasons to Purchase this Report
Contact US:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Urethral Stricture Treatment Market Current Trends And Lucrative Opportunities In Technology – 2027 appeared first on Gatorledger.
The article discusses the Urethral Stricture Treatment market trends and growth opportunities.
Growth is driven by increasing urethral stricture cases and technological innovations.
Urethroplasty has a success rate of over 85% for treating urethral strictures.
Explore more articles in the Research Reports category











